Inari Medical Announces Promotion of Drew Hykes to Chief Operating Officer

Rhea-AI Summary

Inari Medical (NASDAQ: NARI) announced the promotion of Drew Hykes to Chief Operating Officer, effective September 1, 2020. Hykes, who joined Inari as Chief Commercial Officer in 2017, will now oversee Research, Product Development, Manufacturing, Operations, Quality, and Regulatory in addition to Commercial functions. CEO Bill Hoffman lauded Hykes for his significant contributions to commercial success and his commitment to the mission of improving patient lives. Inari is focused on developing minimally-invasive solutions for treating venous conditions, including the ClotTriever and FlowTriever systems.

Positive

• Drew Hykes' promotion may enhance organizational leadership and operational efficiency.
• Hykes' prior experience at Sequent Medical and Medtronic brings valuable expertise.

Negative

• Potential concerns around continuity in leadership with significant role expansion.

IRVINE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the promotion of Drew Hykes to Chief Operating Officer, effective September 1, 2020.  In his expanded role, Mr. Hykes will now have responsibility for Research, Product Development, Manufacturing, Operations, Quality and Regulatory, in addition to the Commercial functions.

Mr. Hykes joined Inari as Chief Commercial Officer in September 2017.  Prior to Inari, Mr. Hykes served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market.  Prior to Sequent, Mr. Hykes spent twelve years at Medtronic in various roles including the VP of Marketing and VP of Clinical and Regulatory for the AF Solutions business, and Director of Investor Relations.  Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions.  He received his B.B.A. from the University of Wisconsin Madison and an M.B.A. from Harvard Business School.

“Drew has had a significant impact on our commercial success over the last three years,” said Bill Hoffman, CEO of Inari Medical. “Under Drew’s leadership, we have rapidly built a highly effective and efficient commercial organization dedicated to improving the lives of patients suffering from venous thromboembolism.  This promotion not only recognizes this record of accomplishment, but his passion for Inari’s mission.”

"It's an honor to continue to help Inari Medical bring new technologies to many more physicians and their patients," said Hykes. “We have built an outstanding organization, with talented people fully dedicated to changing the lives of patients suffering from life-threatening blood clots."

About Inari Medical, Inc.
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.

Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.

Investor Contact:
Westwicke Partners
Caroline Corner
Phone +1-415-202-5678 
caroline.corner@westwicke.com

FAQ

What are the responsibilities of Drew Hykes as COO of Inari Medical?

Drew Hykes will oversee Research, Product Development, Manufacturing, Operations, Quality, Regulatory, and Commercial functions.

When did Drew Hykes take over as COO of Inari Medical?

Drew Hykes became COO effective September 1, 2020.

What prior roles did Drew Hykes hold before becoming COO?

Before his promotion, Hykes was the Chief Commercial Officer at Inari and held positions at Sequent Medical and Medtronic.

What is Inari Medical's focus in the healthcare industry?

Inari Medical focuses on developing products to treat venous diseases, particularly through mechanical thrombectomy solutions.